Journal of Clinical Endocrinology & Metabolism, Vol 75, 358-361, Copyright © 1992 by Endocrine Society

ARTICLES

Peculiar distribution of adipose tissue in patients with congenital generalized lipodystrophy

A Garg, JL Fleckenstein, RM Peshock and SM Grundy
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235.

Congenital generalized lipodystrophy (CGL) is a rare genetic disease with extreme paucity of fat from birth which is believed to be generalized, involving the whole body. Affected patients are characterized by severe insulin resistance. Sites of adipose tissue distribution in patients with CGL have not been studied systematically. Therefore, the fat distribution in three women (17-20 yr old) with CGL was investigated. Determination of body composition by underwater volume displacement suggested the complete absence of body fat (range, - 3 to -7%; normal, 15-25%). Whole body magnetic resonance imaging, however, detected fat in particular anatomical sites, namely in orbits, palms and soles, and periarticular and epidural regions. Some fat was also localized in the tongue, breasts, vulva, and buccal area. Fat in other subcutaneous areas, intraabdominal and intrathoracic regions, and bone marrow was essentially absent. Thus, patients with CGL do not have a complete absence of body fat; of interest, fat is present in those sites where adipose tissue may be serving mainly a mechanical function. Patients with CGL, therefore, provided a unique opportunity to identify the various sites of localization of "mechanical" adipose tissue in the human body. Our study suggests that the genetic defect in CGL results in poor growth and development of metabolically active adipose tissue, whereas mechanical adipose tissue is well preserved.

This article has been cited by other articles:

				A. Garg and A. K. Agarwal Caveolin-1: A New Locus for Human Lipodystrophy J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1183 - 1185. [Full Text] [PDF]

				J. Jin, L. Cao, Z. Zhao, S. Shen, W. Kiess, D. Zhi, R. Ye, R. Cheng, L. Chen, Y. Yang, et al. Novel BSCL2 gene mutation E189X in Chinese congenital generalized lipodystrophy child with early onset diabetes mellitus Eur. J. Endocrinol., December 1, 2007; 157(6): 783 - 787. [Abstract] [Full Text] [PDF]

				M. Fu, R. Kazlauskaite, M. d. F. Paiva Baracho, M. G. D. Nascimento Santos, J. Brandao-Neto, S. Villares, F. S. Celi, B. L. Wajchenberg, and A. R. Shuldiner Mutations in Gng3lg and AGPAT2 in Berardinelli-Seip Congenital Lipodystrophy and Brunzell Syndrome: Phenotype Variability Suggests Important Modifier Effects J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2916 - 2922. [Abstract] [Full Text] [PDF]

				A. Garg Acquired and Inherited Lipodystrophies N. Engl. J. Med., March 18, 2004; 350(12): 1220 - 1234. [Full Text] [PDF]

				V. Simha and A. Garg Phenotypic Heterogeneity in Body Fat Distribution in Patients with Congenital Generalized Lipodystrophy Caused by Mutations in the AGPAT2 or Seipin Genes J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5433 - 5437. [Abstract] [Full Text] [PDF]

				Q. He, E. S. Engelson, J. B. Albu, S. B. Heymsfield, and D. P. Kotler Preferential loss of omental-mesenteric fat during growth hormone therapy of HIV-associated lipodystrophy J Appl Physiol, May 1, 2003; 94(5): 2051 - 2057. [Abstract] [Full Text] [PDF]

				V. Simha, L. S. Szczepaniak, A. J. Wagner, A. M. DePaoli, and A. Garg Effect of Leptin Replacement on Intrahepatic and Intramyocellular Lipid Content in Patients With Generalized Lipodystrophy Diabetes Care, January 1, 2003; 26(1): 30 - 35. [Abstract] [Full Text] [PDF]

				V. Simha, J. E. Zerwekh, K. Sakhaee, and A. Garg Effect of Subcutaneous Leptin Replacement Therapy on Bone Metabolism in Patients with Generalized Lipodystrophy J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 4942 - 4945. [Abstract] [Full Text] [PDF]

				E. A. Oral, E. Ruiz, A. Andewelt, N. Sebring, A. J. Wagner, A. M. Depaoli, and P. Gorden Effect of Leptin Replacement on Pituitary Hormone Regulation in Patients with Severe Lipodystrophy J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3110 - 3117. [Abstract] [Full Text] [PDF]

				E. A. Oral, V. Simha, E. Ruiz, A. Andewelt, A. Premkumar, P. Snell, A. J. Wagner, A. M. DePaoli, M. L. Reitman, S. I. Taylor, et al. Leptin-Replacement Therapy for Lipodystrophy N. Engl. J. Med., February 21, 2002; 346(8): 570 - 578. [Abstract] [Full Text] [PDF]

				V. Simha and A. Garg Body Fat Distribution and Metabolic Derangements in Patients with Familial Partial Lipodystrophy Associated with Mandibuloacral Dysplasia J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 776 - 785. [Abstract] [Full Text] [PDF]

				B. L. Wajchenberg Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome Endocr. Rev., December 1, 2000; 21(6): 697 - 738. [Abstract] [Full Text]

				D. Chen and A. Garg Monogenic disorders of obesity and body fat distribution J. Lipid Res., October 1, 1999; 40(10): 1735 - 1746. [Abstract] [Full Text]

				L. S. Szczepaniak, E. E. Babcock, F. Schick, R. L. Dobbins, A. Garg, D. K. Burns, J. D. McGarry, and D. T. Stein Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo Am J Physiol Endocrinol Metab, May 1, 1999; 276(5): E977 - E989. [Abstract] [Full Text] [PDF]

				A. Garg, R. M. Peshock, and J. L. Fleckenstein Adipose Tissue Distribution Pattern in Patients with Familial Partial Lipodystrophy (Dunnigan Variety) J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 170 - 174. [Abstract] [Full Text]

				I. Shimomura, R. E. Hammer, J. A. Richardson, S. Ikemoto, Y. Bashmakov, J. L. Goldstein, and M. S. Brown Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy Genes & Dev., October 15, 1998; 12(20): 3182 - 3194. [Abstract] [Full Text]

				V. C. Pardini, I. M. N. Victória, S. M. V. Rocha, D. G. Andrade, A. M. Rocha, F. B. Pieroni, G. Milagres, S. Purisch, and G. Velho Leptin Levels, {beta}-Cell Function, and Insulin Sensitivity in Families with Congenital and Acquired Generalized Lipoatropic Diabetes J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 503 - 508. [Abstract] [Full Text]